ለውጦች
On ሰኔ 30, 2022, 16:47:59 (SAST),
-
Set format of resource Vaccine types to CSV in Africa/global vaccination rollouts
-
Uploaded a new file to resource Vaccine types in Africa/global vaccination rollouts
-
Changed value of field
datastore_active
toTrue
in resource Vaccine types in Africa/global vaccination rollouts -
Changed value of field
url_type
toupload
in resource Vaccine types in Africa/global vaccination rollouts
f | 1 | { | f | 1 | { |
2 | "author": "Gemma Ritchie", | 2 | "author": "Gemma Ritchie", | ||
3 | "author_email": "[email protected]", | 3 | "author_email": "[email protected]", | ||
4 | "creator_user_id": "251278fa-64c7-42e2-a21a-5bb96c670399", | 4 | "creator_user_id": "251278fa-64c7-42e2-a21a-5bb96c670399", | ||
5 | "extras": [], | 5 | "extras": [], | ||
6 | "groups": [], | 6 | "groups": [], | ||
7 | "id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | 7 | "id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | ||
8 | "isopen": true, | 8 | "isopen": true, | ||
9 | "license_id": "cc-by", | 9 | "license_id": "cc-by", | ||
10 | "license_title": "Creative Commons Attribution", | 10 | "license_title": "Creative Commons Attribution", | ||
11 | "license_url": "http://www.opendefinition.org/licenses/cc-by", | 11 | "license_url": "http://www.opendefinition.org/licenses/cc-by", | ||
12 | "maintainer": "Gemma Ritchie", | 12 | "maintainer": "Gemma Ritchie", | ||
13 | "maintainer_email": "[email protected]", | 13 | "maintainer_email": "[email protected]", | ||
14 | "metadata_created": "2022-06-30T06:48:12.490391", | 14 | "metadata_created": "2022-06-30T06:48:12.490391", | ||
n | 15 | "metadata_modified": "2022-06-30T07:36:16.478293", | n | 15 | "metadata_modified": "2022-06-30T14:47:59.254970", |
16 | "name": "africa-global-vaccination-rollouts", | 16 | "name": "africa-global-vaccination-rollouts", | ||
17 | "notes": "<p>This folder has three files: </p>\r\n<ul>\r\n<li><p>- A | 17 | "notes": "<p>This folder has three files: </p>\r\n<ul>\r\n<li><p>- A | ||
18 | table of the types of Covid-19 vaccines and their manufacturers which | 18 | table of the types of Covid-19 vaccines and their manufacturers which | ||
19 | are fully approved or approved only for emergency use</p>\r\n<p>- A | 19 | are fully approved or approved only for emergency use</p>\r\n<p>- A | ||
20 | table of countries that have approved the Covid-19 | 20 | table of countries that have approved the Covid-19 | ||
21 | vaccines</p>\r\n<p>- A table of doses delivered to | 21 | vaccines</p>\r\n<p>- A table of doses delivered to | ||
22 | countries</p>\r\n</ul>\r\n\r\n<br />*This data was last updated on 30 | 22 | countries</p>\r\n</ul>\r\n\r\n<br />*This data was last updated on 30 | ||
23 | June 2022.*. \r\n<br />*For the full methodology see this file | 23 | June 2022.*. \r\n<br />*For the full methodology see this file | ||
24 | n1vuWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)*", | 24 | n1vuWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)*", | ||
25 | "num_resources": 3, | 25 | "num_resources": 3, | ||
26 | "num_tags": 5, | 26 | "num_tags": 5, | ||
27 | "organization": { | 27 | "organization": { | ||
28 | "approval_status": "approved", | 28 | "approval_status": "approved", | ||
29 | "created": "2022-06-29T10:06:22.005628", | 29 | "created": "2022-06-29T10:06:22.005628", | ||
30 | "description": "Media Hack Collective collect, analyse, and | 30 | "description": "Media Hack Collective collect, analyse, and | ||
31 | visualise data to tell engaging and effective stories. Media Hack | 31 | visualise data to tell engaging and effective stories. Media Hack | ||
32 | Collective are a partner organisation in the Africa Data Hub. Their | 32 | Collective are a partner organisation in the Africa Data Hub. Their | ||
33 | website can be found [here](https://mediahack.co.za/)", | 33 | website can be found [here](https://mediahack.co.za/)", | ||
34 | "id": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | 34 | "id": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | ||
35 | "image_url": "https://mediahack.co.za/_images/logo.png", | 35 | "image_url": "https://mediahack.co.za/_images/logo.png", | ||
36 | "is_organization": true, | 36 | "is_organization": true, | ||
37 | "name": "media-hack-collective", | 37 | "name": "media-hack-collective", | ||
38 | "revision_id": "f7699549-076b-4559-b7e5-039726d1ff76", | 38 | "revision_id": "f7699549-076b-4559-b7e5-039726d1ff76", | ||
39 | "state": "active", | 39 | "state": "active", | ||
40 | "title": "Media Hack Collective", | 40 | "title": "Media Hack Collective", | ||
41 | "type": "organization" | 41 | "type": "organization" | ||
42 | }, | 42 | }, | ||
43 | "owner_org": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | 43 | "owner_org": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | ||
44 | "private": false, | 44 | "private": false, | ||
45 | "relationships_as_object": [], | 45 | "relationships_as_object": [], | ||
46 | "relationships_as_subject": [], | 46 | "relationships_as_subject": [], | ||
47 | "resources": [ | 47 | "resources": [ | ||
48 | { | 48 | { | ||
49 | "cache_last_updated": null, | 49 | "cache_last_updated": null, | ||
50 | "cache_url": null, | 50 | "cache_url": null, | ||
51 | "created": "2022-06-30T07:07:52.749707", | 51 | "created": "2022-06-30T07:07:52.749707", | ||
n | 52 | "datastore_active": false, | n | 52 | "datastore_active": true, |
53 | "description": "<p>This dataset contains descriptive information | 53 | "description": "<p>This dataset contains descriptive information | ||
54 | about vaccines that are in use in countries around the world or have | 54 | about vaccines that are in use in countries around the world or have | ||
55 | been approved for use (emergency, limited, or full approval), along | 55 | been approved for use (emergency, limited, or full approval), along | ||
56 | with information on who manufacturers the vaccine, type of vaccine, | 56 | with information on who manufacturers the vaccine, type of vaccine, | ||
57 | number of doses required etc. New vaccines will be added when they are | 57 | number of doses required etc. New vaccines will be added when they are | ||
58 | either approved by a country, or a country starts to vaccinate with | 58 | either approved by a country, or a country starts to vaccinate with | ||
59 | them. </p> \r\n<br /> *Data as of 30 June 2022*. \r\n\r\n<br | 59 | them. </p> \r\n<br /> *Data as of 30 June 2022*. \r\n\r\n<br | ||
60 | />##Description of variables\r\n<br />**ID:**ID number. \r\n\r\n<br /> | 60 | />##Description of variables\r\n<br />**ID:**ID number. \r\n\r\n<br /> | ||
61 | **Vaccine_platform_acronymn:**Acronym for platform used to carry the | 61 | **Vaccine_platform_acronymn:**Acronym for platform used to carry the | ||
62 | vaccine. \r\n\r\n<br />**Vaccine_platform_description:** Description | 62 | vaccine. \r\n\r\n<br />**Vaccine_platform_description:** Description | ||
63 | of platform used to carry the vaccine. \r\n\r\n<br | 63 | of platform used to carry the vaccine. \r\n\r\n<br | ||
64 | />**Number_of_doses:** Number of doses of vaccine needed to be fully | 64 | />**Number_of_doses:** Number of doses of vaccine needed to be fully | ||
65 | vaccinated. \r\n\r\n<br />**Dosing_schedule** Days when vaccines | 65 | vaccinated. \r\n\r\n<br />**Dosing_schedule** Days when vaccines | ||
66 | should be delivered. \r\n\r\n<br />**Route_of_administration:** How is | 66 | should be delivered. \r\n\r\n<br />**Route_of_administration:** How is | ||
67 | vaccine administered. \r\n\r\n<br />**Type_of_vaccine:** Description | 67 | vaccine administered. \r\n\r\n<br />**Type_of_vaccine:** Description | ||
68 | of the type of vaccine. \r\n\r\n<br />**Names:** The name of the | 68 | of the type of vaccine. \r\n\r\n<br />**Names:** The name of the | ||
69 | vaccine, this is sometimes more like a product code than a name eg | 69 | vaccine, this is sometimes more like a product code than a name eg | ||
70 | BBIBP-CorV, or Ad26.COV2.S. Some vaccines appear to have more than one | 70 | BBIBP-CorV, or Ad26.COV2.S. Some vaccines appear to have more than one | ||
71 | name. \r\n\r\n<br />**Common_name:** The most commonly used name of a | 71 | name. \r\n\r\n<br />**Common_name:** The most commonly used name of a | ||
72 | vaccine. eg, BBIBP-CorV is more commonly known as the Sinopharm | 72 | vaccine. eg, BBIBP-CorV is more commonly known as the Sinopharm | ||
73 | vaccine and Ad26.COV2.S is the Johnson & Johnson vaccine. | 73 | vaccine and Ad26.COV2.S is the Johnson & Johnson vaccine. | ||
74 | \r\n\r\n<br />**storage:** Temperature at which vaccine has to be | 74 | \r\n\r\n<br />**storage:** Temperature at which vaccine has to be | ||
75 | stored. \r\n\r\n<br />**Developers:** Name of company that developed | 75 | stored. \r\n\r\n<br />**Developers:** Name of company that developed | ||
76 | the vaccine. \r\n\r\n<br />**Country_of_origin:** Country or countries | 76 | the vaccine. \r\n\r\n<br />**Country_of_origin:** Country or countries | ||
77 | developer company is based. \r\n\r\n<br />**Phase:** Phase of clinical | 77 | developer company is based. \r\n\r\n<br />**Phase:** Phase of clinical | ||
78 | trial. \r\n\r\n<br />**Covax:** Yes or No variable. Is the vaccine | 78 | trial. \r\n\r\n<br />**Covax:** Yes or No variable. Is the vaccine | ||
79 | part of the Covax initiative? \r\n\r\n<br | 79 | part of the Covax initiative? \r\n\r\n<br | ||
80 | />**WHO_emergency_use_listing:** Description of where the vaccine is | 80 | />**WHO_emergency_use_listing:** Description of where the vaccine is | ||
81 | in the WHO\u2019s emergency listing process. \r\n\r\n<br | 81 | in the WHO\u2019s emergency listing process. \r\n\r\n<br | ||
82 | />**Data_of_who_recommendation:** Date on which WHO emergency use | 82 | />**Data_of_who_recommendation:** Date on which WHO emergency use | ||
83 | listing was approved\r\n \r\n\r\n<br />**efficacy_1:** Percentage. | 83 | listing was approved\r\n \r\n\r\n<br />**efficacy_1:** Percentage. | ||
84 | What is the vaccine\u2019s efficacy on \u201cwild\u201d SARS-Cov-2 | 84 | What is the vaccine\u2019s efficacy on \u201cwild\u201d SARS-Cov-2 | ||
85 | virus from Phase 3 or 4 clinical trials? \r\n\r\n<br /> | 85 | virus from Phase 3 or 4 clinical trials? \r\n\r\n<br /> | ||
86 | **efficacy_RSA:** Percentage. What is the efficacy of the virus when | 86 | **efficacy_RSA:** Percentage. What is the efficacy of the virus when | ||
87 | tested against the B.1.315 variant, which is dominant in South Africa? | 87 | tested against the B.1.315 variant, which is dominant in South Africa? | ||
88 | \r\n\r\n<br />**date_of_test_results_1:** Date the efficacy_1 results | 88 | \r\n\r\n<br />**date_of_test_results_1:** Date the efficacy_1 results | ||
89 | were published. \r\n\r\n<br />**Results_published:** No means results | 89 | were published. \r\n\r\n<br />**Results_published:** No means results | ||
90 | have not been published in peer-reviewed journal. Name of journal if | 90 | have not been published in peer-reviewed journal. Name of journal if | ||
91 | results have been published. \r\n\r\n<br | 91 | results have been published. \r\n\r\n<br | ||
92 | />**date_results-published:**Date when results were published in | 92 | />**date_results-published:**Date when results were published in | ||
93 | peer-reviewed journal\r\n\r\n<br /> | 93 | peer-reviewed journal\r\n\r\n<br /> | ||
94 | j6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)\r\n\r\n\r\n", | 94 | j6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)\r\n\r\n\r\n", | ||
n | 95 | "format": "", | n | 95 | "format": "CSV", |
96 | "hash": "", | 96 | "hash": "", | ||
97 | "id": "f2f33f2f-2be1-4f65-9751-b2cbbd5446a4", | 97 | "id": "f2f33f2f-2be1-4f65-9751-b2cbbd5446a4", | ||
n | 98 | "last_modified": null, | n | 98 | "last_modified": "2022-06-30T14:47:59.228959", |
99 | "mimetype": null, | 99 | "mimetype": null, | ||
100 | "mimetype_inner": null, | 100 | "mimetype_inner": null, | ||
101 | "name": "Vaccine types", | 101 | "name": "Vaccine types", | ||
102 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | 102 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | ||
103 | "position": 0, | 103 | "position": 0, | ||
104 | "resource_type": null, | 104 | "resource_type": null, | ||
n | 105 | "revision_id": "82cc0340-c8f3-4377-926d-bbb3e75b55bd", | n | 105 | "revision_id": "26941984-04f4-4eaa-9669-1e1494bde049", |
106 | "size": null, | 106 | "size": null, | ||
107 | "state": "active", | 107 | "state": "active", | ||
108 | "url": | 108 | "url": | ||
t | 109 | B5PAr1oErpwp1PyG_bb9nEFTPql/pub?gid=883047759&single=true&output=csv", | t | 109 | 51-b2cbbd5446a4/download/who-vaccines-data-working-copy-vaccines.csv", |
110 | "url_type": "" | 110 | "url_type": "upload" | ||
111 | }, | 111 | }, | ||
112 | { | 112 | { | ||
113 | "cache_last_updated": null, | 113 | "cache_last_updated": null, | ||
114 | "cache_url": null, | 114 | "cache_url": null, | ||
115 | "created": "2022-06-30T07:15:41.065396", | 115 | "created": "2022-06-30T07:15:41.065396", | ||
116 | "datastore_active": false, | 116 | "datastore_active": false, | ||
117 | "description": "<p> This dataset contains a list of countries | 117 | "description": "<p> This dataset contains a list of countries | ||
118 | and the types of Covid vaccines they are using. It includes when | 118 | and the types of Covid vaccines they are using. It includes when | ||
119 | vaccination started for each vaccine type, where the vaccine is fully | 119 | vaccination started for each vaccine type, where the vaccine is fully | ||
120 | approved for use in that country, the date of approval, where | 120 | approved for use in that country, the date of approval, where | ||
121 | available, and whether it is supplied by Covax. </p>\r\n<p>**Source:** | 121 | available, and whether it is supplied by Covax. </p>\r\n<p>**Source:** | ||
122 | Multiple sources. See | 122 | Multiple sources. See | ||
123 | nmvn1vuWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub) | 123 | nmvn1vuWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub) | ||
124 | section. Also sources are in the dataset.</p>\r\n\r\n<br />*This data | 124 | section. Also sources are in the dataset.</p>\r\n\r\n<br />*This data | ||
125 | was last updated on 30 June 2022.* \r\n\r\n<br /> Description of | 125 | was last updated on 30 June 2022.* \r\n\r\n<br /> Description of | ||
126 | variables. \r\n================================== \r\n<br | 126 | variables. \r\n================================== \r\n<br | ||
127 | />**iso_code:** 3-letter ISO country code. \r\n\r\n<br | 127 | />**iso_code:** 3-letter ISO country code. \r\n\r\n<br | ||
128 | />**continent:** Name of continent. \r\n\r\n<br />**country:** Name of | 128 | />**continent:** Name of continent. \r\n\r\n<br />**country:** Name of | ||
129 | country. \r\n\r\n<br />**common _name:** The most commonly used name | 129 | country. \r\n\r\n<br />**common _name:** The most commonly used name | ||
130 | of a vaccine. eg, BBIBP-CorV is more commonly known as the Sinopharm | 130 | of a vaccine. eg, BBIBP-CorV is more commonly known as the Sinopharm | ||
131 | vaccine and Ad26.COV2.S is the Johnson & Johnson vaccine. | 131 | vaccine and Ad26.COV2.S is the Johnson & Johnson vaccine. | ||
132 | \r\n\r\n<br />**supplier_name:** Name of company that developed the | 132 | \r\n\r\n<br />**supplier_name:** Name of company that developed the | ||
133 | vaccine. Same as develop variable in Sheet 1: Vaccines. \r\n\r\n<br | 133 | vaccine. Same as develop variable in Sheet 1: Vaccines. \r\n\r\n<br | ||
134 | />**authorised_emergency_use:** Yes or blank cell. The table of | 134 | />**authorised_emergency_use:** Yes or blank cell. The table of | ||
135 | vaccines used by countries around the world is triggered by a Yes. | 135 | vaccines used by countries around the world is triggered by a Yes. | ||
136 | \r\n\r\n<br />**date_authorised_emergency_use:** Date when a | 136 | \r\n\r\n<br />**date_authorised_emergency_use:** Date when a | ||
137 | country\u2019s health ministry authorised a vaccine for emergency or | 137 | country\u2019s health ministry authorised a vaccine for emergency or | ||
138 | limited use. \r\n\r\n<br />**vaccination_started:** Yes or blank cell. | 138 | limited use. \r\n\r\n<br />**vaccination_started:** Yes or blank cell. | ||
139 | The table of vaccines used by countries around the world is triggered | 139 | The table of vaccines used by countries around the world is triggered | ||
140 | by a Yes. As is the Africa map vaccine tracker\r\n\r\n<br | 140 | by a Yes. As is the Africa map vaccine tracker\r\n\r\n<br | ||
141 | />**date_vaccination _started:** Date country started to vaccinate | 141 | />**date_vaccination _started:** Date country started to vaccinate | ||
142 | people with a vaccine. \r\n\r\n<br />**approved:** Yes or blank cell. | 142 | people with a vaccine. \r\n\r\n<br />**approved:** Yes or blank cell. | ||
143 | Has a vaccine been fully approved by a country? \r\n\r\n<br | 143 | Has a vaccine been fully approved by a country? \r\n\r\n<br | ||
144 | />**date_approved:** Date country announced full approval for a | 144 | />**date_approved:** Date country announced full approval for a | ||
145 | vaccine. \r\n\r\n<br />**covax_supplied:** Yes or blank cell. Did | 145 | vaccine. \r\n\r\n<br />**covax_supplied:** Yes or blank cell. Did | ||
146 | country receive vaccine through Covax initiative? \r\n\r\n<br | 146 | country receive vaccine through Covax initiative? \r\n\r\n<br | ||
147 | />**authorised_source:** URLs of all the sources for the data in the | 147 | />**authorised_source:** URLs of all the sources for the data in the | ||
148 | authorised_emergency_use, date_athorised_emergency_use, approved and | 148 | authorised_emergency_use, date_athorised_emergency_use, approved and | ||
149 | date_approved variables. List of URLs, separated by semicolons. | 149 | date_approved variables. List of URLs, separated by semicolons. | ||
150 | \r\n\r\n<br />**vaccination_source:** URLs of all the sources for the | 150 | \r\n\r\n<br />**vaccination_source:** URLs of all the sources for the | ||
151 | data in the vaccination_started and date_vaccination_started | 151 | data in the vaccination_started and date_vaccination_started | ||
152 | variables. List of URLs, separated by semicolons. | 152 | variables. List of URLs, separated by semicolons. | ||
153 | uWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)\r\n", | 153 | uWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)\r\n", | ||
154 | "format": "", | 154 | "format": "", | ||
155 | "hash": "", | 155 | "hash": "", | ||
156 | "id": "b905738c-ce6a-40d6-b628-482a48364993", | 156 | "id": "b905738c-ce6a-40d6-b628-482a48364993", | ||
157 | "last_modified": null, | 157 | "last_modified": null, | ||
158 | "mimetype": null, | 158 | "mimetype": null, | ||
159 | "mimetype_inner": null, | 159 | "mimetype_inner": null, | ||
160 | "name": "Africa/global vaccination rollouts", | 160 | "name": "Africa/global vaccination rollouts", | ||
161 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | 161 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | ||
162 | "position": 1, | 162 | "position": 1, | ||
163 | "resource_type": null, | 163 | "resource_type": null, | ||
164 | "revision_id": "3f1ea78d-a86c-476b-a496-f67e82cc9316", | 164 | "revision_id": "3f1ea78d-a86c-476b-a496-f67e82cc9316", | ||
165 | "size": null, | 165 | "size": null, | ||
166 | "state": "active", | 166 | "state": "active", | ||
167 | "url": | 167 | "url": | ||
168 | B5PAr1oErpwp1PyG_bb9nEFTPql/pub?gid=495726462&single=true&output=csv", | 168 | B5PAr1oErpwp1PyG_bb9nEFTPql/pub?gid=495726462&single=true&output=csv", | ||
169 | "url_type": null | 169 | "url_type": null | ||
170 | }, | 170 | }, | ||
171 | { | 171 | { | ||
172 | "cache_last_updated": null, | 172 | "cache_last_updated": null, | ||
173 | "cache_url": null, | 173 | "cache_url": null, | ||
174 | "created": "2022-06-30T07:20:31.078417", | 174 | "created": "2022-06-30T07:20:31.078417", | ||
175 | "datastore_active": false, | 175 | "datastore_active": false, | ||
176 | "description": "<p>This dataset lists all countries that have | 176 | "description": "<p>This dataset lists all countries that have | ||
177 | received vaccines from the Covax initiative, through bi-lateral | 177 | received vaccines from the Covax initiative, through bi-lateral | ||
178 | donations, bought from pharmaceutical companies, from the Africa | 178 | donations, bought from pharmaceutical companies, from the Africa | ||
179 | Vaccine Acquisition Trust, the vaccine received, the number of doses | 179 | Vaccine Acquisition Trust, the vaccine received, the number of doses | ||
180 | and the date received. </p>\r\n\r\n<br /> *Last updated on 30 June | 180 | and the date received. </p>\r\n\r\n<br /> *Last updated on 30 June | ||
181 | 2022*. \r\n\r\n<br />**iso_code:** 3-letter ISO country code. | 181 | 2022*. \r\n\r\n<br />**iso_code:** 3-letter ISO country code. | ||
182 | \r\n\r\n<br />**continent:** Name of continent. \r\n\r\n<br | 182 | \r\n\r\n<br />**continent:** Name of continent. \r\n\r\n<br | ||
183 | />**country:** Name of country. \r\n\r\n<br />**common _name:** The | 183 | />**country:** Name of country. \r\n\r\n<br />**common _name:** The | ||
184 | most commonly used name of a vaccine. eg, BBIBP-CorV is more commonly | 184 | most commonly used name of a vaccine. eg, BBIBP-CorV is more commonly | ||
185 | known as the Sinopharm vaccine and Ad26.COV2.S is the Johnson & | 185 | known as the Sinopharm vaccine and Ad26.COV2.S is the Johnson & | ||
186 | Johnson vaccine. \r\n\r\n<br />**supplier_name:** Name of company | 186 | Johnson vaccine. \r\n\r\n<br />**supplier_name:** Name of company | ||
187 | that developed the vaccine. \r\n \r\n<br />**doses_received:** Number | 187 | that developed the vaccine. \r\n \r\n<br />**doses_received:** Number | ||
188 | of doses received in a particular shipment. \r\n\r\n<br | 188 | of doses received in a particular shipment. \r\n\r\n<br | ||
189 | />**bought_donated:** \u201cBought\u201d means a country bought the | 189 | />**bought_donated:** \u201cBought\u201d means a country bought the | ||
190 | vaccines, \u201cDonated\u201d means they were donated, | 190 | vaccines, \u201cDonated\u201d means they were donated, | ||
191 | \u201cCovax\u201d means they came via Covax, \u201cprivate\u201d when | 191 | \u201cCovax\u201d means they came via Covax, \u201cprivate\u201d when | ||
192 | private institutions buy vaccines; \u201csold\u201d when a country | 192 | private institutions buy vaccines; \u201csold\u201d when a country | ||
193 | sells vaccines they received to another country; | 193 | sells vaccines they received to another country; | ||
194 | \u201cdonated-out\u201d is when a country donates vaccines to another | 194 | \u201cdonated-out\u201d is when a country donates vaccines to another | ||
195 | with no expectation of reciprocity. \r\n\r\n<br />**donor:** Name of | 195 | with no expectation of reciprocity. \r\n\r\n<br />**donor:** Name of | ||
196 | the country or group of countries supplying the vaccines received. | 196 | the country or group of countries supplying the vaccines received. | ||
197 | \r\n\r\n<br />**covax:** Yes or No variable. Is the vaccine part of | 197 | \r\n\r\n<br />**covax:** Yes or No variable. Is the vaccine part of | ||
198 | the Covax initiative? \r\n\r\n<br />**date_received:** Date shipment | 198 | the Covax initiative? \r\n\r\n<br />**date_received:** Date shipment | ||
199 | of vaccines was delivered. \r\n\r\n<br />**source:** URL link to | 199 | of vaccines was delivered. \r\n\r\n<br />**source:** URL link to | ||
200 | source of information. \r\n\r\n<br />**source_2:** URL link to source | 200 | source of information. \r\n\r\n<br />**source_2:** URL link to source | ||
201 | of information. \r\n\r\n<br />**source_3:** URL link to source of | 201 | of information. \r\n\r\n<br />**source_3:** URL link to source of | ||
202 | vn1vuWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)", | 202 | vn1vuWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)", | ||
203 | "format": "", | 203 | "format": "", | ||
204 | "hash": "", | 204 | "hash": "", | ||
205 | "id": "09545054-d15d-45a0-b49a-3ab37a934c78", | 205 | "id": "09545054-d15d-45a0-b49a-3ab37a934c78", | ||
206 | "last_modified": null, | 206 | "last_modified": null, | ||
207 | "mimetype": null, | 207 | "mimetype": null, | ||
208 | "mimetype_inner": null, | 208 | "mimetype_inner": null, | ||
209 | "name": "Global vaccine deliveries", | 209 | "name": "Global vaccine deliveries", | ||
210 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | 210 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | ||
211 | "position": 2, | 211 | "position": 2, | ||
212 | "resource_type": null, | 212 | "resource_type": null, | ||
213 | "revision_id": "f2037452-452a-4455-9de1-37ed9c9e491c", | 213 | "revision_id": "f2037452-452a-4455-9de1-37ed9c9e491c", | ||
214 | "size": null, | 214 | "size": null, | ||
215 | "state": "active", | 215 | "state": "active", | ||
216 | "url": | 216 | "url": | ||
217 | B5PAr1oErpwp1PyG_bb9nEFTPql/pub?gid=789081741&single=true&output=csv", | 217 | B5PAr1oErpwp1PyG_bb9nEFTPql/pub?gid=789081741&single=true&output=csv", | ||
218 | "url_type": null | 218 | "url_type": null | ||
219 | } | 219 | } | ||
220 | ], | 220 | ], | ||
221 | "revision_id": "5b989075-6345-4728-a105-deeb6efe13da", | 221 | "revision_id": "5b989075-6345-4728-a105-deeb6efe13da", | ||
222 | "state": "active", | 222 | "state": "active", | ||
223 | "tags": [ | 223 | "tags": [ | ||
224 | { | 224 | { | ||
225 | "display_name": "Africa", | 225 | "display_name": "Africa", | ||
226 | "id": "011a15dd-a5a0-470e-bb50-86536530d821", | 226 | "id": "011a15dd-a5a0-470e-bb50-86536530d821", | ||
227 | "name": "Africa", | 227 | "name": "Africa", | ||
228 | "state": "active", | 228 | "state": "active", | ||
229 | "vocabulary_id": null | 229 | "vocabulary_id": null | ||
230 | }, | 230 | }, | ||
231 | { | 231 | { | ||
232 | "display_name": "Covax", | 232 | "display_name": "Covax", | ||
233 | "id": "abf146ec-dc99-4a7c-979c-052791e475c8", | 233 | "id": "abf146ec-dc99-4a7c-979c-052791e475c8", | ||
234 | "name": "Covax", | 234 | "name": "Covax", | ||
235 | "state": "active", | 235 | "state": "active", | ||
236 | "vocabulary_id": null | 236 | "vocabulary_id": null | ||
237 | }, | 237 | }, | ||
238 | { | 238 | { | ||
239 | "display_name": "Covid-19", | 239 | "display_name": "Covid-19", | ||
240 | "id": "e1e63920-b518-40c0-89dc-f13aa4c02737", | 240 | "id": "e1e63920-b518-40c0-89dc-f13aa4c02737", | ||
241 | "name": "Covid-19", | 241 | "name": "Covid-19", | ||
242 | "state": "active", | 242 | "state": "active", | ||
243 | "vocabulary_id": null | 243 | "vocabulary_id": null | ||
244 | }, | 244 | }, | ||
245 | { | 245 | { | ||
246 | "display_name": "Covid-19 vaccines", | 246 | "display_name": "Covid-19 vaccines", | ||
247 | "id": "5c7bebc8-269d-495a-9148-8b9619a3c4d9", | 247 | "id": "5c7bebc8-269d-495a-9148-8b9619a3c4d9", | ||
248 | "name": "Covid-19 vaccines", | 248 | "name": "Covid-19 vaccines", | ||
249 | "state": "active", | 249 | "state": "active", | ||
250 | "vocabulary_id": null | 250 | "vocabulary_id": null | ||
251 | }, | 251 | }, | ||
252 | { | 252 | { | ||
253 | "display_name": "vaccines", | 253 | "display_name": "vaccines", | ||
254 | "id": "223adf5d-c358-41a8-bcb7-d0c4008bf122", | 254 | "id": "223adf5d-c358-41a8-bcb7-d0c4008bf122", | ||
255 | "name": "vaccines", | 255 | "name": "vaccines", | ||
256 | "state": "active", | 256 | "state": "active", | ||
257 | "vocabulary_id": null | 257 | "vocabulary_id": null | ||
258 | } | 258 | } | ||
259 | ], | 259 | ], | ||
260 | "title": "Africa/global vaccination rollouts", | 260 | "title": "Africa/global vaccination rollouts", | ||
261 | "type": "dataset", | 261 | "type": "dataset", | ||
262 | "url": "Multiple sources. See Methodology section", | 262 | "url": "Multiple sources. See Methodology section", | ||
263 | "version": "" | 263 | "version": "" | ||
264 | } | 264 | } |